These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8579104)

  • 21. Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach.
    Tamura G; Sakata K; Maesawa C; Suzuki Y; Terashima M; Satoh K; Sekiyama S; Suzuki A; Eda Y; Satodate R
    Cancer Res; 1995 May; 55(9):1933-6. PubMed ID: 7728762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of p53 gene mutations in primary neuroblastomas.
    Vogan K; Bernstein M; Leclerc JM; Brisson L; Brossard J; Brodeur GM; Pelletier J; Gros P
    Cancer Res; 1993 Nov; 53(21):5269-73. PubMed ID: 8221661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of p53 gene in primary gastric cancer tissues.
    Hong SI; Hong WS; Jang JJ; Lee DS; Cho NS; Jung ME; Kim HB; Ha GW; Park IC; Cho DS
    Anticancer Res; 1994; 14(3B):1251-5. PubMed ID: 8067692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer.
    Ficorella C; Cannita K; Ricevuto E; Toniato E; Fusco C; Sinopoli NT; De Galitiis F; Di Rocco ZC; Porzio G; Frati L; Gulino A; Martinotti S; Marchetti P
    Oncol Rep; 2003; 10(1):169-73. PubMed ID: 12469165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
    Yoshimoto K; Iwahana H; Fukuda A; Sano T; Saito S; Itakura M
    Cancer Res; 1992 Sep; 52(18):5061-4. PubMed ID: 1516062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
    Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
    Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
    Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
    Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
    Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Greater sensitivity of the PCR-SSCP technique compared with immunohistochemistry for the detection of exon 5 and 6 mutations of gene 53 in breast cancer].
    Dueñas González A; Cruz Hernández JJ; Abad Hernández MM; Ramos M; González Sarmiento R
    Med Clin (Barc); 1996 May; 106(19):721-4. PubMed ID: 8801382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of p53 gene mutations in colorectal carcinomas from an Asian population.
    Shi CY; Phang TW; Ngoi SS; Wee A; Li B; Lin Y; Lee HP; Ong CN
    Anticancer Res; 1994; 14(6B):2811-6. PubMed ID: 7872723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infrequent mutation of the p53 gene in fibrous tumors of infancy and childhood.
    Boman F; Peters J; Ragge N; Triche T
    Diagn Mol Pathol; 1993 Mar; 2(1):14-22. PubMed ID: 8287221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of hereditary mutations in exons 5 through 9 of the p53 gene and exon 24 of the neurofibromin gene in families with glioma.
    van Meyel DJ; Ramsay DA; Chambers AF; Macdonald DR; Cairncross JG
    Ann Neurol; 1994 Jan; 35(1):120-2. PubMed ID: 8285583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis.
    Tessitore A; Di Rocco ZC; Cannita K; Ricevuto E; Toniato E; Tosi M; Ficorella C; Frati L; Gulino A; Marchetti P; Martinotti S
    Genes Chromosomes Cancer; 2002 Sep; 35(1):86-91. PubMed ID: 12203794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature.
    Kulla A; Burkhardt K; Meyer-Puttlitz B; Teesalu T; Asser T; Wiestler OD; Becker AJ
    Acta Neuropathol; 2003 Apr; 105(4):328-32. PubMed ID: 12624785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
    Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
    J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations of p53 in Wilms' tumors.
    Takeuchi S; Bartram CR; Ludwig R; Royer-Pokora B; Schneider S; Imamura J; Koeffler HP
    Mod Pathol; 1995 Jun; 8(5):483-7. PubMed ID: 7675765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
    Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.